ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: DTP Combines Two Branches; Robert Cooper Names DCPC Board Chairman Weicker Receives MSK Award

June 28, 1985

In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor

February 14, 1992

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

RFA For Patterns Of Care Studies Announced By DCCR

November 10, 1978

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

Survival After Liver Transplant Called Excellent In Study

November 28, 2003